Experimentally, small molecule inhibitors, such as MLN4924, have been shown to suppress CRL activation by inhibition of cullin activity, and, in turn, to effectively reduce the growth of various human cancer cells in vitro [6]. This evidence concerns the gene IL31RA and cancer.